Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
Clinical trial NCT04668235 · COMPLETED
Trial details
- NCT number
- NCT04668235
- Sponsor
- HRH Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-23
- Primary completion
- 2022-08-10
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.